Preclinical Platform Using a Triple-negative Breast Cancer Syngeneic Murine Model to Evaluate Immune Checkpoint Inhibitors.
Katuwal NB, Park N, Pandey K, Kang MS, Hong SD, Ghosh M, Kim SG, Cho YB, Hur J, Kim SK, Moon YW.
Katuwal NB, et al.
Anticancer Res. 2023 Jan;43(1):85-95. doi: 10.21873/anticanres.16137.
Anticancer Res. 2023.
PMID: 36585194
At the time of sacrifice, analyses of tumor infiltrating lymphocytes consistently supported these results. We also demonstrated that retro-orbital blood sampling procedures (baseline, 7 days post-treatment, time of sacrifice) were safe for serum cytokine analyses, s …
At the time of sacrifice, analyses of tumor infiltrating lymphocytes consistently supported these results. We also demonstrated that retr …